Pages with the most revisions

Jump to navigation Jump to search

Showing below up to 250 results in range #101 to #350.

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)

  1. Rigidity threshold‏‎ (3 revisions)
  2. Dose of record (E)‏‎ (3 revisions)
  3. Low Earth orbit‏‎ (3 revisions)
  4. Accountability‏‎ (3 revisions)
  5. X ray‏‎ (3 revisions)
  6. Half-life, physical‏‎ (3 revisions)
  7. Cell death‏‎ (3 revisions)
  8. Contamination‏‎ (3 revisions)
  9. Exponential survival curve‏‎ (3 revisions)
  10. Unsealed source‏‎ (3 revisions)
  11. Xerostomia‏‎ (3 revisions)
  12. Annual limit on intake‏‎ (3 revisions)
  13. Dose per content function‏‎ (3 revisions)
  14. Interphase death‏‎ (3 revisions)
  15. Equity‏‎ (3 revisions)
  16. Test‏‎ (3 revisions)
  17. Graded approach‏‎ (3 revisions)
  18. Public exposure‏‎ (3 revisions)
  19. Fractionation‏‎ (3 revisions)
  20. Uptake‏‎ (3 revisions)
  21. Active (red) bone marrow‏‎ (3 revisions)
  22. Utilitarian ethics‏‎ (3 revisions)
  23. Granulocyte-macrophage colony-stimulating factor‏‎ (3 revisions)
  24. Operational quantity‏‎ (3 revisions)
  25. Value judgement‏‎ (3 revisions)
  26. Granulocyte colony-stimulating factor‏‎ (3 revisions)
  27. Coster-Kronig transition‏‎ (3 revisions)
  28. Emergency preparedness‏‎ (3 revisions)
  29. Valvular heart disease‏‎ (3 revisions)
  30. Gray‏‎ (3 revisions)
  31. Personal dose equivalent‏‎ (3 revisions)
  32. Principle of justification‏‎ (3 revisions)
  33. Radiofrequency ablation‏‎ (3 revisions)
  34. Iso-effect plots‏‎ (3 revisions)
  35. Emergency procedures‏‎ (3 revisions)
  36. Lifetime risk estimates‏‎ (3 revisions)
  37. Absolute risk‏‎ (3 revisions)
  38. Virtue ethics‏‎ (3 revisions)
  39. Auger transition‏‎ (3 revisions)
  40. Bystander effect‏‎ (3 revisions)
  41. Derived air concentration‏‎ (3 revisions)
  42. Dignity‏‎ (3 revisions)
  43. Isomers‏‎ (3 revisions)
  44. Employer‏‎ (3 revisions)
  45. Activity median thermodynamic diameter‏‎ (3 revisions)
  46. Voxel phantom‏‎ (3 revisions)
  47. Radiological Protection in Healthcare‏‎ (3 revisions - redirect page)
  48. Complex tissues‏‎ (3 revisions)
  49. Growth fraction‏‎ (3 revisions)
  50. Organ dose equivalent‏‎ (3 revisions)
  51. Excretion rate (instantaneous)‏‎ (3 revisions)
  52. Extrathoracic airways‏‎ (3 revisions)
  53. Galactic cosmic radiation‏‎ (3 revisions)
  54. Growth hormone (somatotropin)‏‎ (3 revisions)
  55. ICRP Publication 103‏‎ (3 revisions)
  56. Spread-out Bragg peak‏‎ (3 revisions)
  57. Fairness‏‎ (3 revisions)
  58. Absorption‏‎ (3 revisions)
  59. Gamma ray‏‎ (3 revisions)
  60. Recovery‏‎ (3 revisions)
  61. DNA damage signalling‏‎ (3 revisions)
  62. Retrievability‏‎ (2 revisions)
  63. Immune system‏‎ (2 revisions)
  64. Institutional control‏‎ (2 revisions)
  65. Stakeholder‏‎ (2 revisions)
  66. Environmental radiation protection‏‎ (2 revisions)
  67. Tachycardia‏‎ (2 revisions)
  68. Exemption level‏‎ (2 revisions)
  69. Tissue equivalent material‏‎ (2 revisions)
  70. Myocardial stress test‏‎ (2 revisions)
  71. Oversight‏‎ (2 revisions)
  72. Projected dose‏‎ (2 revisions)
  73. Co-expertise‏‎ (2 revisions)
  74. Radionuclides of natural origin‏‎ (2 revisions)
  75. Connective tissue‏‎ (2 revisions)
  76. Recovery (cellular or tissue)‏‎ (2 revisions)
  77. DRL process‏‎ (2 revisions)
  78. Reversibility‏‎ (2 revisions)
  79. In vivo radiobioassay‏‎ (2 revisions)
  80. Solar particle event‏‎ (2 revisions)
  81. Effective dose equivalent‏‎ (2 revisions)
  82. Existing exposure situation‏‎ (2 revisions)
  83. Gastroschisis‏‎ (2 revisions)
  84. Worker‏‎ (2 revisions)
  85. Nuclear track detectors‏‎ (2 revisions)
  86. Angiogenesis‏‎ (2 revisions)
  87. Hyperbaric oxygen‏‎ (2 revisions)
  88. Bioturbation‏‎ (2 revisions)
  89. Cardioverter-defibrillator‏‎ (2 revisions)
  90. Radiation safety officer‏‎ (2 revisions)
  91. Radioresponsiveness‏‎ (2 revisions)
  92. Consequential late effects‏‎ (2 revisions)
  93. Recovery responder‏‎ (2 revisions)
  94. Rehabilitation of living conditions‏‎ (2 revisions)
  95. Right to know‏‎ (2 revisions)
  96. Incidence‏‎ (2 revisions)
  97. Solar wind‏‎ (2 revisions)
  98. Epithelium‏‎ (2 revisions)
  99. Target tissue‏‎ (2 revisions)
  100. Measuring and Reducing Radon Levels in your Home‏‎ (2 revisions)
  101. Acceptance test‏‎ (2 revisions)
  102. Gastrulation‏‎ (2 revisions)
  103. Working level‏‎ (2 revisions)
  104. OLINDA/EXM‏‎ (2 revisions)
  105. Habitual mouth breather‏‎ (2 revisions)
  106. Annihilation photons‏‎ (2 revisions)
  107. Particle radiance‏‎ (2 revisions)
  108. Hyperfractionation‏‎ (2 revisions)
  109. Bone marrow‏‎ (2 revisions)
  110. Protection strategy‏‎ (2 revisions)
  111. Radiation source‏‎ (2 revisions)
  112. Cohort study‏‎ (2 revisions)
  113. Radiosensitiser‏‎ (2 revisions)
  114. DRL value‏‎ (2 revisions)
  115. Rigidity‏‎ (2 revisions)
  116. Dose-length product‏‎ (2 revisions)
  117. Security‏‎ (2 revisions)
  118. Incident‏‎ (2 revisions)
  119. Intermediate level waste‏‎ (2 revisions)
  120. Stenosis‏‎ (2 revisions)
  121. Equieffective dose‏‎ (2 revisions)
  122. Local DRL‏‎ (2 revisions)
  123. Expanded and aligned radiation field‏‎ (2 revisions)
  124. Tolerability‏‎ (2 revisions)
  125. Medical exposure‏‎ (2 revisions)
  126. Naturally occurring radioactive material‏‎ (2 revisions)
  127. Adventitious‏‎ (2 revisions)
  128. Working level month‏‎ (2 revisions)
  129. Habitual nose breather‏‎ (2 revisions)
  130. Hypertrophic cardiomyopathy‏‎ (2 revisions)
  131. Background dose (rate)‏‎ (2 revisions)
  132. Radiosensitivity, cellular‏‎ (2 revisions)
  133. Containment‏‎ (2 revisions)
  134. Detriment‏‎ (2 revisions)
  135. Dose-rate effect‏‎ (2 revisions)
  136. Inclusiveness‏‎ (2 revisions)
  137. Source-related‏‎ (2 revisions)
  138. Internal conversion electron‏‎ (2 revisions)
  139. Electron-capture decay‏‎ (2 revisions)
  140. LD 50/30‏‎ (2 revisions)
  141. Telangiectasia‏‎ (2 revisions)
  142. Member of the public‏‎ (2 revisions)
  143. Fluoroscopically or computed tomography guided interventions‏‎ (2 revisions)
  144. Unattached fraction‏‎ (2 revisions)
  145. Necrosis‏‎ (2 revisions)
  146. Patient entrance reference point‏‎ (2 revisions)
  147. Hypoplasia‏‎ (2 revisions)
  148. Backscatter detection system‏‎ (2 revisions)
  149. Potential recoverability correction factor‏‎ (2 revisions)
  150. Bradycardia‏‎ (2 revisions)
  151. Protective action guide‏‎ (2 revisions)
  152. Radiation worker‏‎ (2 revisions)
  153. Decay constant‏‎ (2 revisions)
  154. Self-help protection‏‎ (2 revisions)
  155. Individual-related‏‎ (2 revisions)
  156. Dose of record Hp (10)‏‎ (2 revisions)
  157. Electrophysiology‏‎ (2 revisions)
  158. Storage‏‎ (2 revisions)
  159. Track structure‏‎ (2 revisions)
  160. Mendelian diseases‏‎ (2 revisions)
  161. Accreditation‏‎ (2 revisions)
  162. Neurological syndrome‏‎ (2 revisions)
  163. Genomic integrity‏‎ (2 revisions)
  164. Occupational exposure‏‎ (2 revisions)
  165. Hazard‏‎ (2 revisions)
  166. Peak skin dose‏‎ (2 revisions)
  167. Bragg peak‏‎ (2 revisions)
  168. Radioactive dispersion device‏‎ (2 revisions)
  169. Radon: Units of Measure‏‎ (2 revisions)
  170. Coronary heart disease‏‎ (2 revisions)
  171. Reference air kerma‏‎ (2 revisions)
  172. Decommissioning‏‎ (2 revisions)
  173. ICRP Task Groups on Radiological Protection in Healthcare‏‎ (2 revisions)
  174. Dose-threshold‏‎ (2 revisions)
  175. Individual decontamination‏‎ (2 revisions)
  176. Subcutaneous tissue‏‎ (2 revisions)
  177. Low dose rate‏‎ (2 revisions)
  178. Transfer compartment‏‎ (2 revisions)
  179. Mitigation‏‎ (2 revisions)
  180. Fractional absorption in the gastrointestinal tract‏‎ (2 revisions)
  181. Action Level‏‎ (2 revisions)
  182. Upper reference levels‏‎ (2 revisions)
  183. Neurovascular syndrome‏‎ (2 revisions)
  184. Health Surveillance‏‎ (2 revisions)
  185. Pelagic‏‎ (2 revisions)
  186. Basal cell‏‎ (2 revisions)
  187. Practical radiological protection culture‏‎ (2 revisions)
  188. Branching fraction‏‎ (2 revisions)
  189. Chronic exposure‏‎ (2 revisions)
  190. Radioactive source‏‎ (2 revisions)
  191. Colony‏‎ (2 revisions)
  192. Cosmic Radiation in Aviation‏‎ (2 revisions)
  193. Decontamination‏‎ (2 revisions)
  194. Relocation‏‎ (2 revisions)
  195. Diastasis‏‎ (2 revisions)
  196. Risk coefficient‏‎ (2 revisions)
  197. Individual monitoring‏‎ (2 revisions)
  198. Dose per unit intake coefficient‏‎ (2 revisions)
  199. Source term‏‎ (2 revisions)
  200. Emergency‏‎ (2 revisions)
  201. Latent time/period or latency interval‏‎ (2 revisions)
  202. Low level waste‏‎ (2 revisions)
  203. Exposure, external or internal‏‎ (2 revisions)
  204. Graft vs host disease‏‎ (2 revisions)
  205. Air-kerma, incident‏‎ (2 revisions)
  206. Heliosphere‏‎ (2 revisions)
  207. Qualified expert‏‎ (2 revisions)
  208. Class SR-0 gases‏‎ (2 revisions)
  209. Radioactive substance‏‎ (2 revisions)
  210. Reference biokinetic model‏‎ (2 revisions)
  211. Decontamination factor‏‎ (2 revisions)
  212. Remedial action‏‎ (2 revisions)
  213. ICRPædia Guide to Dose Coefficients‏‎ (2 revisions)
  214. Dose rate‏‎ (2 revisions)
  215. Intervention Level‏‎ (2 revisions)
  216. Emergency exposure situation‏‎ (2 revisions)
  217. Substantial radiation dose level‏‎ (2 revisions)
  218. Erythropoietin‏‎ (2 revisions)
  219. Exposure (in the context of inhalation)‏‎ (2 revisions)
  220. Transfer rate‏‎ (2 revisions)
  221. Multi-detector computed tomography‏‎ (2 revisions)
  222. Fractionation and dose delivery patterns‏‎ (2 revisions)
  223. Percutaneous coronary intervention‏‎ (2 revisions)
  224. Prevailing circumstances‏‎ (2 revisions)
  225. Broad beam therapy irradiation technique‏‎ (2 revisions)
  226. Class SR-1 gases‏‎ (2 revisions)
  227. Committed effective dose‏‎ (2 revisions)
  228. Radon Recommendations for Authorities‏‎ (2 revisions)
  229. Cost-benefit analysis‏‎ (2 revisions)
  230. Reference individual‏‎ (2 revisions)
  231. Remediation‏‎ (2 revisions)
  232. Dichotomous‏‎ (2 revisions)
  233. Risk of Exposure to Radon‏‎ (2 revisions)
  234. Dose rate effectiveness factor‏‎ (2 revisions)
  235. South Atlantic anomaly‏‎ (2 revisions)
  236. Interventional procedure‏‎ (2 revisions)
  237. Emergency plan‏‎ (2 revisions)
  238. Ethics‏‎ (2 revisions)
  239. Lymphatic system‏‎ (2 revisions)
  240. ALARA‏‎ (2 revisions)
  241. Transforming growth factor‏‎ (2 revisions)
  242. Hierarchical tissues‏‎ (2 revisions)
  243. Area monitoring‏‎ (2 revisions)
  244. Pericarditis‏‎ (2 revisions)
  245. Benthic‏‎ (2 revisions)
  246. Principle of application of dose limits‏‎ (2 revisions)
  247. Bronchial region‏‎ (2 revisions)
  248. Class SR-2 gases‏‎ (2 revisions)
  249. Radioactivity‏‎ (2 revisions)
  250. Committed equivalent dose‏‎ (2 revisions)

View (previous 250 | next 250) (20 | 50 | 100 | 250 | 500)